| |

nes
This vaccine is important because
meningococcal disease is the leading cause of bacterial
meningitis in children between the ages of 2 and 18 years.
Approximately 1,400 to 2,800 people living in the United
States are diagnosed with a meningococcal disease annually,
and 10 percent to 15 percent die. The death rate in
teens and young adults with meningococcal disease is greater
than 20 percent. Another 11 percent to 19 percent suffer
life-long conditions including deafness, mental retardation,
seizures, strokes, severe skin scarring requiring skin
grafts, and loss of limbs or digits.
The meningococcal vaccine protects against four of the five
types of meningococcal bacteria. Prevention is the key to
not contracting meningococcal disease, and the most effective
preventive method is the meningococcal vaccine.
|
Who should receive the meningococcal vaccines?
Each meningococcal vaccine is recommended for different age
groups and for varying specific circumstances.
The meningococcal vaccine MPSV4 or MCV4 should be given to children
between the ages of 2 years and 10 years who are at high
risk for meningococcal disease (those without a spleen or a
damaged spleen, those with certain immune deficiencies,
those exposed during an outbreak and those traveling to
parts of the world where meningococcal disease is common).
Meningococcal conjugate vaccine (MCV4) is recommended for
all 11-to-18 year olds who have never received a
meningococcal vaccination at their annual medical visits. College students who will be living in
dormitories who have never received a meningococcal
vaccination also should get the MCV4 vaccine.
People 11 to 55 years of age at high risk for meningococcal
disease should be inoculated with the meningococcal vaccine
MCV4 including:
-
Military recruits
-
People
traveling to parts of the
world where meningococcal disease is common
-
Anyone who has been exposed to a
meningococcal disease outbreak
-
Microbiologists who could be
exposed to meningococcal disease in the laboratory
-
People who have a damaged spleen
or have had their spleen removed
-
People with certain immune
deficiencies (e.g., complement) or who have had bone marrow
transplants
Those who should not
be vaccinated with MCV4 include:
-
Children under 11 years of age and
adults over 55 years of age
-
People who have experienced a
severe allergic reaction to any vaccine component or a previous
dose of any meningococcal vaccine
-
Anyone who is moderately to
severely ill
-
Pregnant women unless they are
involved in an outbreak or at high risk
-
Those who have ever been diagnosed
with Guillain-Barré Syndrome
should discuss this vaccine with their primary
health care provider before being inoculated.
Review the
vaccination
schedule for those who start late on a vaccine or are more than one
month behind.
|
When did the meningococcal vaccines become available?
In 1978, the first meningococcal vaccine (MPSV2) was
approved for use in the United States against two types of
meningococcal bacteria. In 1982, the vaccine was further
developed to protect against two more types of meningococcal
bacteria, and the FDA licensed MPSV4. In 2005, a new
meningococcal vaccine (MCV4) that provides a longer duration
of protection as well as several other benefits was approved
for use among people between the ages of 11 and 55 years.
How does someone become infected with meningococcal
disease?
Meningococcal disease is spread by close personal contact.
How effective is the meningococcal vaccine?
The Meningococcal vaccines MPSV4 and MCV4 are highly
effective at protecting recipients from diseases caused by
four types of meningococcal bacteria (types A, C, Y and
W-135). Even though they don’t protect against meningococcal
bacteria type B, they still give those who have been
vaccinated a much higher level of protection against
meningococcal disease.
Are there any serious side effects of the meningococcal
vaccines?
Mild side effects may include:
-
injection-site soreness
-
fever
In very rare cases, a serious
allergic reaction may occur.
How do I learn more about these vaccines?
The best person to ask about these vaccines or any vaccine
is your child’s pediatrician or your primary health care
provider. Your provider can answer your questions and give
you more information on the meningococcal vaccines.
Immunization is the best thing you can do for your child and yourself to protect against meningococcal disease.
 
|
|